Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Genworth Financial Inc Common Stock (GNW) vs Stryker Corporation (SYK) Price & Performance

Genworth Financial Inc Common StockTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Genworth Financial Inc Common Stock vs Stryker Corporation — how do they compare? Genworth Financial Inc Common Stock trades at $8.82 (market cap $3.36B), while Stryker Corporation trades at $285 (market cap $108.38B). The key difference: Stryker Corporation is far larger — about 32.3× Genworth Financial Inc Common Stock's market cap, and Stryker Corporation pays a 1.25% dividend while Genworth Financial Inc Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Genworth Financial Inc Common Stock for 0 Days and Stryker Corporation for 22 Days on average.

GNWSYK
Market Cap
$3.36B$108.38B
Volume
3,333,1562,068,363
Sector
FinancialsHealth
52-Week High
$10.60$388.35
52-Week Low
$7.94$269.75
Typical Hold Time
0 Days22 Days
Enterprise Value
$2.87B$119.84B
Dividend Yield
—1.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Genworth Financial Inc Common Stock

Genworth Financial (GNW) trades at $8.89, down 1.77% today, with neutral technical signals and mixed fundamental performance. The company maintains stable revenue around $7.1-7.2B but faces margin pressure, with net income declining from $223M to $212M year-over-year. Recent Q2 2026 earnings beat expectations at $0.29 EPS, while the company expanded its share repurchase program by $500M in September 2026.

GNW presents value characteristics with low P/B (0.38) and P/S (0.49) ratios, but weak profitability metrics (ROE 2.42%) and analyst caution (70.59% hold rating) suggest limited near-term catalysts. Key risks include legacy insurance liabilities and competitive pressures, while the upcoming Q3 earnings on November 4 could provide directional clarity.

Stryker Corporation

Stryker (SYK) trades at $282.63, showing minimal daily movement. The stock exhibits a neutral technical stance with mixed moving averages and oscillators. Fundamentally, SYK maintains strong profitability with a 14.43% net income margin and 16.51% ROE, though a P/E of 29.28 suggests a premium valuation. Recent news highlights ongoing legal scrutiny over a manufacturing issue disclosed in September 2026, which caused a significant price drop. Q3 2026 earnings are anticipated on October 29, 2026, following a mix of beats and misses in prior quarters.

The outlook for SYK is cautiously optimistic, supported by analyst consensus with a $365.89 price target and no sell ratings. Investment appeal lies in its solid cash flow and market position, but risks include legal investigations and persistent operational challenges. The stock's near-term direction will likely hinge on Q3 earnings results and clarity on the manufacturing issue resolution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GNW
100% Buy0% Sell
Avg holding period · 0 Days
SYK
100% Buy0% Sell
Avg holding period · 22 Days

Top news

Latest headlines on both assets

About Genworth Financial Inc Common Stock

Genworth Financial, Inc. is a holding company that provides products and services related to aging and long-term care planning, and is the parent company of publicly traded mortgage insurer Enact Holdings, Inc.

Read more on GNW →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →